PMV Re Vinci nv, based in Brussels, Belgium, is primarily focused on real estate development. The company plays a significant role in fostering the Flemish economy by providing funding to promising businesses from their inception through various growth stages and into international operations. Collaborating with government entities and other partners, PMV implements projects that are vital for prosperity and well-being in Flanders. The organization is dedicated to supporting entrepreneurship as a key driver of economic development and believes that sustainable business ventures must ultimately achieve profitability. Through its investments, PMV aims to ensure that every supported project contributes positively to the economic landscape of Flanders.
Taglayer provides online personalization software that enables websites to deliver tailored content to visitors based on their behavior. By analyzing user interactions, Taglayer's platform allows companies to enhance their websites, ensuring that the most relevant information is presented to each visitor. This targeted approach aims to improve on-site conversion rates and increase revenue by aligning content with customer interests, all while preserving user anonymity. Through its all-in-one marketing application, Taglayer assists businesses in creating dynamic content that resonates with their audience, ultimately fostering a more engaging online experience.
Markmi
Seed Round in 2025
Markmi is an AI assistant designed for fashion retail teams. It provides markdown recommendations and insights to help teams make data-driven decisions to protect margins and drive profitability. It allows users to simulate markdown strategies, predict sales outcomes, and make smarter decisions faster, without spreadsheets
ClimateCamp
Seed Round in 2025
ClimateCamp is a developer of a greenhouse gas accounting platform aimed at de-carbonizing supply chains. The platform provides detailed information on carbon emissions throughout the supply chain, enabling companies to gain a comprehensive view of their carbon footprint. By facilitating collaboration among key stakeholders, ClimateCamp offers up-to-date insights into emissions, allowing businesses to efficiently target their reduction efforts.
Augustine Therapeutics
Series A in 2025
Augustine Therapeutics N.V., founded in 2019 and based in Gent, Belgium, focuses on developing innovative medicines for patients suffering from Charcot-Marie-Tooth disease and other neuromuscular disorders. The company is engaged in two drug discovery programs aimed at identifying new generations of selective HDAC6 inhibitors, which are designed to address axonopathies, including Charcot-Marie-Tooth disease. These novel compounds are intended to protect against nerve degeneration and facilitate the repair of peripheral myelin and axons. By advancing these therapeutic drugs, Augustine Therapeutics aims to enhance the quality of life for patients affected by these debilitating conditions.
Nobi
Series B in 2025
Nobi is a smart lamp that ensures help can be provided in a flash in the event of a fall. It recognizes a fall, and it will notify a family member, contacts, or a specialized emergency call center. The lamp will then connect to that person to reassure them that help is on the way. If necessary, it can even unlock the smart lock on the front door.
Swave Photonics
Series A in 2025
Swave Photonics specializes in the design and marketing of holographic chips utilizing proprietary diffractive photonics technology. The company aims to enhance augmented reality experiences through its innovative NanoPixel technology, which allows for the creation of compact, lightweight, and high-resolution displays. By focusing on the integration of digital content with the real world, Swave Photonics seeks to empower display manufacturers and content creators to produce immersive, ultra-high-resolution holographic displays. This approach contributes to the development of a more interactive metaverse, enabling users to visualize complex concepts, collaborate effectively, and achieve greater outcomes.
Apideck
Series A in 2024
Apideck is a company that assists B2B SaaS businesses in enhancing their integration strategies through the use of Unified APIs. By providing a single integration layer, Apideck enables engineering teams to develop API integrations more efficiently, allowing them to concentrate on product development. The company offers tools that facilitate real-time visibility across various APIs and webhooks while simplifying credential management, including API keys and OAuth flows. This streamlined approach helps companies reduce integration delivery times, conserve development resources, and ultimately increase revenue. With a rapidly expanding ecosystem of APIs, Apideck positions itself as a vital partner for organizations looking to optimize their integration processes.
Minze Health
Series A in 2024
Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract problems, particularly focusing on urologic, pelvic health, and continence care. Its platform facilitates the diagnostic and treatment processes, as well as remote patient monitoring for individuals suffering from lower urinary tract symptoms (LUTS). Minze Health's innovative solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers around the globe, enabling healthcare professionals to effectively diagnose and monitor their patients both in clinical settings and private practices.
PanTera
Series A in 2024
PanTera focuses on the large-scale production of actinium-225, a promising radioisotope for targeted cancer therapies. The company aims to improve accessibility to personalized nuclear medicine treatments while ensuring sustainability through the recycling of materials in their production process.
Accurat
Seed Round in 2024
Accurat is a location intelligence startup focused on understanding consumer behavior through big data and geo-analytics. The company operates an AI-powered platform that tracks and segments app users into actionable categories, allowing for predictions of future shopping behavior. By integrating user, location, and context data, Accurat provides retail brands and media publishers with insights that enhance their media and retail strategies. The platform's plug-and-play SDK offers a flexible solution, delivering first-party insights as opposed to relying on third-party data. Accurat aims to create a direct impact for advertisers and publishers by enabling them to attribute the effects of various campaign efforts in a comprehensive manner.
Confo Therapeutics
Series B in 2024
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company focuses on developing internal drug discovery programs centered on G-protein coupled receptors (GPCRs), which are critical targets for therapeutic intervention. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes active-state conformations of GPCRs, enabling researchers to access previously unreachable structural features. This innovation facilitates the discovery of novel agonists, addressing unmet medical needs and potentially leading to improved treatments in the medical field. The company aims to build a robust portfolio of drug discovery programs, leveraging its unique approach to enhance therapeutic options.
Monarch Tractor
Series C in 2024
Monarch Tractor specializes in the development of fully electric, autonomous tractors aimed at improving agricultural productivity and sustainability. These tractors are designed to operate without human intervention, utilizing advanced sensors, artificial intelligence, and machine learning to navigate fields, monitor crop health, and perform various farming tasks. By significantly reducing reliance on fossil fuels, Monarch tractors help farmers lower their carbon footprint and work towards sustainability goals. The integrated sensors collect valuable data on crop health, soil conditions, and other key variables, allowing for data-driven insights that enable farmers to optimize their practices, reduce costs, and increase yields.
Augustine Therapeutics
Series A in 2024
Augustine Therapeutics N.V., founded in 2019 and based in Gent, Belgium, focuses on developing innovative medicines for patients suffering from Charcot-Marie-Tooth disease and other neuromuscular disorders. The company is engaged in two drug discovery programs aimed at identifying new generations of selective HDAC6 inhibitors, which are designed to address axonopathies, including Charcot-Marie-Tooth disease. These novel compounds are intended to protect against nerve degeneration and facilitate the repair of peripheral myelin and axons. By advancing these therapeutic drugs, Augustine Therapeutics aims to enhance the quality of life for patients affected by these debilitating conditions.
TechWolf
Series B in 2024
TechWolf is a company that specializes in an AI-based talent intelligence platform aimed at helping enterprises transition to a skills-based talent model. The platform automatically tracks employees’ skills by analyzing HR information and their digital interactions in the workplace. By utilizing artificial intelligence, TechWolf's software provides organizations with a comprehensive view of their workforce's skills and identifies skill gaps, offering actionable insights regarding current and future skill requirements. This enables companies to make informed decisions that enhance both individual employee development and overall organizational effectiveness.
Gorilla
Series B in 2024
Gorilla focuses on transforming the energy and utility industry through innovative energy data applications. The company addresses longstanding data challenges that hinder innovation by offering a robust architectural data foundation tailored specifically for energy companies. Its platform features a flexible data model and a stable environment, which includes reusable algorithms that facilitate a quicker digital transformation process. By automating data collection and providing tools for pricing, forecasting, and reporting, Gorilla empowers energy retailers to leverage data-driven technology, thereby enhancing their sales while mitigating risks. With offices in Antwerp, London, Austin, and Melbourne, Gorilla is positioned to support energy companies in maximizing their return on investment from data.
MICLEDI Microdisplays
Series A in 2024
MICLEDI Microdisplays BV specializes in designing and manufacturing micro light-emitting diode (microLED) display chips tailored for augmented reality (AR) glasses. Based in Leuven, Belgium, the company operates as a fabless developer, focusing on advanced technology that integrates III/V materials processing, 3D integration, and 300mm silicon-based processing. MICLEDI's proprietary application-specific integrated circuit (ASIC) enables the production of compact, monolithic AR displays that deliver high image quality and enhanced power efficiency. By providing microLED display modules on wafers, MICLEDI serves the semiconductor industry, contributing to the advancement of AR technology.
Protealis
Series B in 2024
Protealis specializes in developing advanced seeds and seed technologies for legume crops, focusing on enhancing their adaptability to the European environment. The company aims to become a leading provider of germplasm for sustainable plant proteins, leveraging innovative breeding techniques and nitrogen fixation. By utilizing proprietary seed coatings and advanced breeding technologies, Protealis seeks to maximize the potential of legume crops. This approach not only helps farmers address protein deficits but also supports local sourcing for the increasing demand from producers of meat and milk alternatives.
Dualyx
Series A in 2023
Dualyx specializes in the discovery and development of biological therapies aimed at treating autoimmune and rare diseases. The company focuses on creating immune modulators, particularly Treg-targeted therapies, which are designed to suppress unwanted autoimmune reactions in patients. By advancing these innovative treatments, Dualyx aims to provide lasting solutions for individuals suffering from autoimmune diseases, ultimately enabling medical professionals to offer effective cures.
dScribe
Seed Round in 2023
dScribe is a company that specializes in data discovery and knowledge sharing through its innovative platform. This platform is designed to streamline the process of cataloging, documenting, and accessing data, allowing users to efficiently find and understand their data assets. It features a robust search engine, personalized suggestions, and advanced filtering capabilities, which enhance the user experience by enabling quick access to relevant information. Additionally, dScribe encourages community engagement by allowing users to contribute definitions, document self-service reports, and suggest improvements to existing content. This collaborative approach aims to enhance data maturity within organizations by providing a centralized entry point for all data-related needs.
IVEX
Seed Round in 2023
IVEX is a start-up originating from the University of Leuven, specializing in the development of tools and software designed for the testing and validation of advanced driver assistance systems (ADAS) and autonomous vehicles. The company comprises a diverse team and has established partnerships with global firms, notably Siemens, to enhance its growth in the high-tech sector. IVEX offers a cloud-based suite of testing and validation tools alongside an onboard real-time safety checker, which can function independently or in conjunction with other systems. Its solutions streamline the analysis of extensive driving data, enabling engineers to efficiently identify and categorize driving scenarios, create digital representations for simulation, and assess safety performance while minimizing computational resource usage. By focusing on safety and efficiency, IVEX aims to support the industry's need for reliable and effective validation of automated driving technologies.
Funkey
Seed Round in 2023
Funkey is a company that specializes in organizing team-building activities by connecting businesses with a curated selection of providers. It offers a matchmaking platform that helps clients find and book the ideal team event based on criteria such as location, budget, and team size. In addition to facilitating events, Funkey provides professional coaching sessions aimed at enhancing teamwork and collaboration among coworkers. Through its services, Funkey aims to foster stronger workplace relationships and improve team dynamics.
Pointerpro
Debt Financing in 2023
Pointerpro is a software platform that creates self online assessments with auto-generated personalized reports in a single tool. Expert advisors, including consultants, coaches, HR professionals, and marketers worldwide, use technology to automate the delivery of personalized advice. Whether your goal is to scale your advisory business, generate leads, or simply save time through automation, Pointerpro makes it easy.
Gorilla
Series A in 2022
Gorilla focuses on transforming the energy and utility industry through innovative energy data applications. The company addresses longstanding data challenges that hinder innovation by offering a robust architectural data foundation tailored specifically for energy companies. Its platform features a flexible data model and a stable environment, which includes reusable algorithms that facilitate a quicker digital transformation process. By automating data collection and providing tools for pricing, forecasting, and reporting, Gorilla empowers energy retailers to leverage data-driven technology, thereby enhancing their sales while mitigating risks. With offices in Antwerp, London, Austin, and Melbourne, Gorilla is positioned to support energy companies in maximizing their return on investment from data.
Minze Health
Seed Round in 2022
Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract problems, particularly focusing on urologic, pelvic health, and continence care. Its platform facilitates the diagnostic and treatment processes, as well as remote patient monitoring for individuals suffering from lower urinary tract symptoms (LUTS). Minze Health's innovative solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers around the globe, enabling healthcare professionals to effectively diagnose and monitor their patients both in clinical settings and private practices.
InvestSuite
Series A in 2022
InvestSuite is a B2B fintech company that provides financial institutions with white-label solutions to enhance their wealth management offerings. The company specializes in developing investment applications that include modular robo-advisory services and self-execution trading platforms. These tools allow institutions to launch their own financial products efficiently and cost-effectively, minimizing the need for significant capital investments. By leveraging advanced technologies like AI and machine learning, InvestSuite helps financial businesses tailor their services to meet the diverse needs of their clients, optimizing investment returns based on individual risk tolerance and financial goals. With a team of experienced experts, InvestSuite is positioned to support the evolving landscape of financial services amid changing customer expectations and technological advancements.
etherna immunotherapies
Series B in 2022
eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.
Morrow Optics
Angel Round in 2022
Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations. Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens. They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel. And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button. In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see.
Qollabi
Seed Round in 2022
Qollabi is a developer of Business Relationship Management (BRM) software aimed at facilitating the management of indirect sales channels, such as agents, distributors, and resellers. The software provides tools for creating centralized partner plans that promote collaboration and communication within teams. It allows users to update action plans and connect with customer relationship management (CRM) systems and other data sources. By leveraging the OKR (Objective & Key Results) methodology, Qollabi enables organizations to establish shared spaces for planning and achieving mutual success with their partners. This approach enhances the effectiveness of partnerships and streamlines the management of business relationships.
LynxCare
Series A in 2022
LynxCare, established in 2015 and headquartered in San Francisco, specializes in an AI-driven data platform. It collects and analyzes structured and unstructured data from diverse sources, offering hospitals and clinics actionable insights to enhance clinical efficiency and improve patient care quality.
Waylay
Series A in 2022
Waylay is a B2B software company that specializes in bridging the gap between operational technology (OT) and information technology (IT). It offers a range of products designed to facilitate digital transformation and enhance operational efficiency. Waylay IO provides low-code automation with no setup required, while Waylay Enterprise simplifies digital transformation for organizations. Additionally, Waylay Digital Twin is a composite application available on the Salesforce AppExchange. The platform aims to integrate various software applications and devices, enabling businesses to make informed decisions based on real-time data from connected equipment. With applications in sectors such as energy, logistics, and online retail, Waylay helps enterprises and small to medium-sized enterprises (SMEs) leverage data and analytical insights to improve operational processes and customer service.
TechWolf
Series A in 2022
TechWolf is a company that specializes in an AI-based talent intelligence platform aimed at helping enterprises transition to a skills-based talent model. The platform automatically tracks employees’ skills by analyzing HR information and their digital interactions in the workplace. By utilizing artificial intelligence, TechWolf's software provides organizations with a comprehensive view of their workforce's skills and identifies skill gaps, offering actionable insights regarding current and future skill requirements. This enables companies to make informed decisions that enhance both individual employee development and overall organizational effectiveness.
CHILI Publish
Venture Round in 2022
CHILI Publish is a Belgium-based company that specializes in online editing software designed to transform original designs into Smart Templates. Founded in 2010 and headquartered in Erembodegem, the company aims to simplify and automate graphic production for businesses across various industries, including marketing, retail, cosmetics, and food and beverage. Its innovative software provides a comprehensive suite of templates and customizable features that facilitate the creation of on-brand visual communications for both print and packaging. By integrating with a wide range of third-party partners, CHILI Publish enables marketers, brands, and printers to utilize a self-service platform, enhancing efficiency in producing graphics for diverse purposes.
Nobi
Venture Round in 2022
Nobi is a smart lamp that ensures help can be provided in a flash in the event of a fall. It recognizes a fall, and it will notify a family member, contacts, or a specialized emergency call center. The lamp will then connect to that person to reassure them that help is on the way. If necessary, it can even unlock the smart lock on the front door.
Moonbird
Venture Round in 2021
Moonbird is a health technology company that specializes in developing a personalized breathing exercise device designed to assist individuals in relaxing and achieving better sleep. The device is a handheld tool that expands and contracts to synchronize with the user's breathing rhythm, facilitating a controlled breathing experience. It is equipped with a photoplethysmography (PPG) sensor and is supported by a mobile application that delivers weekly reports on the user's progress. By using this device, users can effectively lower anxiety, reduce stress levels, and attain a calm state of mind.
Sweepatic
Venture Round in 2021
Sweepatic operates a cloud-based platform focused on External Attack Surface Management, aimed at enhancing cybersecurity for organizations. The platform continuously maps, monitors, and manages all internet-connected assets and associated risks, providing 24/7 observations and high-impact notifications through an intuitive dashboard. By leveraging this technology, Sweepatic helps organizations structure and reduce their external attack surface, thereby minimizing their vulnerability to cyber threats. Headquartered in Belgium, Sweepatic is committed to making its customers more cyber resilient by delivering actionable insights and easy-to-remediate findings.
Sentea
Venture Round in 2021
Sentea specializes in fiber optic sensing technology that provides precise and reliable structural health monitoring solutions. These advanced sensors are designed to predict and prevent equipment failures and structural damage, even in challenging environments. By integrating optical components directly onto a chip, Sentea offers cost-effective sensor interrogators that enhance operational efficiency for industrial installations. The company's innovative approach facilitates the monitoring and improvement of equipment performance, ensuring greater reliability and safety in various applications.
Willow
Venture Round in 2021
Willow is the winning combination of smart technology and experienced experts. Our specialists define your strategy and coach you towards Social Media success. The Willow platform brings inspiration, efficiency & structure. Designed specifically for Professional Service Providers and Busy Entrepreneurs.
RheaVita
Series A in 2021
RheaVita is a pharmaceutical company that specializes in advanced continuous freeze-drying technology for biopharmaceutical products. This innovative technology integrates all steps of the freeze-drying process into a continuous production line, allowing for the constant infeed of products and simultaneous outfeed of dried goods. By improving the manufacturing process, RheaVita's approach addresses the limitations of traditional batch freeze-drying, significantly reducing processing times and minimizing scale-up challenges. The company’s method not only lowers production costs and requires smaller manufacturing facilities with less clean room space, but it also enhances quality assurance through comprehensive inspection and the potential for real-time release. Overall, RheaVita's technology results in improved and consistent product quality, contributing to faster development and reduced time-to-market for pharmaceutical medicines.
Guud Woman
Pre Seed Round in 2021
Guud Woman is a platform dedicated to improving menstrual health for women by providing a range of natural supplements and support. The company offers products aimed at hormonal balance, fertility, and overall well-being, including serums and capsules for skin and hair health. By vertically integrating these resources, Guud Woman aims to empower women to take charge of their health and well-being through accessible and effective solutions tailored to their specific needs.
Aphea.Bio
Series B in 2021
Aphea.Bio focuses on developing innovative agricultural products aimed at enhancing crop health and yields. The company specializes in creating next-generation biopesticides derived from natural microorganisms, which serve as sustainable alternatives to traditional chemical pesticides facing regulatory challenges. Additionally, Aphea.Bio produces biostimulants that promote crop growth by enhancing nutrient uptake from the soil. Utilizing proprietary technologies, the company is dedicated to discovering new biocontrol and biostimulant products that help farmers sustainably manage fungal diseases, pests, and weeds, ultimately improving crop productivity and environmental health.
Neuroventis
Seed Round in 2021
Neuroventis is a digital platform focused on neurology, designed to assist patients in managing their neurological disorders. The platform operates as a CE-marked medical device, allowing users to register their health conditions and share relevant data with their medical teams. By enhancing the interaction between patients and healthcare professionals, Neuroventis aims to empower patients to take an active role in their health management. This approach fosters stronger partnerships in clinical practice and supports patients in overcoming the challenges associated with their conditions.
Dockflow
Pre Seed Round in 2021
Dockflow operates a blockchain-based platform designed to enhance the efficiency and experience of logistics teams. By providing tools for maritime container shipment visibility, tracking, and sensitive cargo monitoring, Dockflow streamlines operations and reduces the burden of manual checks and data management. The platform also facilitates collaboration among logistics professionals, allowing them to focus on delivering better service to customers and engaging in more meaningful tasks. Overall, Dockflow aims to transform logistics operations by automating routine processes and improving communication within the industry.
journy.io
Seed Round in 2021
Journy.io operates an AI-based contextual and behavioral intelligence platform aimed at enhancing the effectiveness of marketing and sales teams. The platform aggregates and consolidates customer data from various web sources and applications, integrating seamlessly with existing organizational tools. By leveraging this unified data, it enables teams to engage in more informed and productive conversations with customers. This approach replaces traditional cold calling methods with data-driven engagement strategies, focusing on high-potential accounts based on their interactions with the product and brand. Ultimately, Journy.io aims to improve sales outcomes by enabling organizations to better understand and respond to customer behavior.
Resortecs
Pre Seed Round in 2021
Resortecs is a company focused on advancing sustainability in the fashion industry through innovative design for disassembly. It offers heat-dissolvable stitching threads and thermal disassembly systems that simplify the recycling process for brands and recyclers. The Smart Stitch™ thread is designed to dissolve at specific temperatures, allowing garments to be easily transformed into recyclable materials from the manufacturing stage. Additionally, the Smart Disassembly™ system enables recyclers to efficiently process large volumes of garments, recovering up to 90% of the original fabric without damaging the material. This solution enhances the ability to recycle textiles, aiming to meet the environmental challenges of the fashion industry while maintaining high standards of quality and design. Resortecs is committed to facilitating the circular economy by making recycling more accessible and effective, ultimately contributing to a more sustainable future in fashion.
reMYND
Series B in 2021
reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for Alzheimer’s, Parkinson’s, diabetes, and other protein-misfolding disorders. The company is advancing several investigational compounds, including ReS19-T for Alzheimer’s and ReS39 for diabetes, as well as ReS3-T, which targets neuronal hyperactivity associated with Alzheimer’s and epilepsy. Additionally, reMYND operates a phenotypic screening platform aimed at discovering small molecule treatments that mitigate the toxicity of misfolded proteins such as Tau and Synuclein. The company also functions as a contract research organization (CRO), providing services that assess the in-vivo characteristics and effects of experimental therapies using proprietary mouse models. This CRO capability has enabled reMYND to support various pharmaceutical clients, including major companies in the United States, Europe, and Japan, by delivering critical proof-of-concept data for drugs in clinical development. Established in 2002, reMYND is committed to addressing the challenges posed by protein misfolding diseases through innovative research and development.
Oqton
Series A in 2021
Oqton develops an innovative factory operating system that integrates engineering software with manufacturing hardware to optimize production processes. Founded in 2017 and headquartered in San Francisco and Ghent, the company focuses on enhancing additive manufacturing workflows through AI-powered solutions. Oqton's FactoryOS captures real-time data from production environments, utilizing AI techniques to provide actionable insights that improve and re-engineer workflows. By linking data across the manufacturing ecosystem—from design to production and logistics—Oqton enables businesses to operate agile factories that can efficiently manage complex product mixes while reducing inventory and simplifying supply chains.
TechWolf
Convertible Note in 2021
TechWolf is a company that specializes in an AI-based talent intelligence platform aimed at helping enterprises transition to a skills-based talent model. The platform automatically tracks employees’ skills by analyzing HR information and their digital interactions in the workplace. By utilizing artificial intelligence, TechWolf's software provides organizations with a comprehensive view of their workforce's skills and identifies skill gaps, offering actionable insights regarding current and future skill requirements. This enables companies to make informed decisions that enhance both individual employee development and overall organizational effectiveness.
InvestSuite
Seed Round in 2020
InvestSuite is a B2B fintech company that provides financial institutions with white-label solutions to enhance their wealth management offerings. The company specializes in developing investment applications that include modular robo-advisory services and self-execution trading platforms. These tools allow institutions to launch their own financial products efficiently and cost-effectively, minimizing the need for significant capital investments. By leveraging advanced technologies like AI and machine learning, InvestSuite helps financial businesses tailor their services to meet the diverse needs of their clients, optimizing investment returns based on individual risk tolerance and financial goals. With a team of experienced experts, InvestSuite is positioned to support the evolving landscape of financial services amid changing customer expectations and technological advancements.
Stellar Labs
Seed Round in 2020
Stellar Labs specializes in transforming workplace learning through its innovative AI-driven platform, which integrates neuroscience-based methodologies to enhance professional development. The company's offerings include a variety of open and customizable learning programs that blend digital training with interactive workshops, peer collaboration, and practical assignments. This approach aims to address the skills gap in the technology sector by ensuring efficient knowledge transfer and real-world application. Key features of the platform include rapid design and delivery of learning experiences, evidence-based training for improved knowledge retention, and adaptive learning paths that personalize education for each individual. Furthermore, Stellar Labs emphasizes measurable outcomes, providing insights into performance improvements and productivity gains within organizations. By fostering a dynamic learning culture, Stellar Labs equips teams with essential skills for the future, ultimately driving enhanced performance and productivity.
Corporify
Series A in 2020
Corporify is a software-as-a-service platform designed to streamline the legal management of companies. By simplifying legal processes, it enhances accuracy and trustworthiness in corporate housekeeping. The platform facilitates fast-track restructurings and buy-and-build strategies, while also addressing compliance risks and reputational concerns. Additionally, Corporify improves group governance and communication among legal stakeholders, ultimately helping businesses save time and money while reducing risks associated with legal formalities.
Aphea.Bio
Series B in 2020
Aphea.Bio focuses on developing innovative agricultural products aimed at enhancing crop health and yields. The company specializes in creating next-generation biopesticides derived from natural microorganisms, which serve as sustainable alternatives to traditional chemical pesticides facing regulatory challenges. Additionally, Aphea.Bio produces biostimulants that promote crop growth by enhancing nutrient uptake from the soil. Utilizing proprietary technologies, the company is dedicated to discovering new biocontrol and biostimulant products that help farmers sustainably manage fungal diseases, pests, and weeds, ultimately improving crop productivity and environmental health.
SettleMint
Debt Financing in 2020
SettleMint offers a user-friendly platform that enables web2 engineers to build, deploy, and integrate applications on web3 infrastructure. The company provides a comprehensive suite of tools covering the entire web3 application development lifecycle. This includes node hosting as a service, customizable smart contract templates for over 50 use cases, and efficient on-chain data querying through Graph QL integration. Additionally, SettleMint supports decentralized data storage with IPFS node deployment, alongside centralized storage options. The platform features a fully automated and customizable user interface builder, ensuring scalability with easy resource management. With SOC2 certification and enterprise-grade capabilities, SettleMint simplifies the complexities of web3 development for businesses across Europe, the Middle East, Africa, India, and Asia-Pacific, with offices in key cities such as Belgium, Dubai, Delhi, Singapore, and Tokyo.
Morrow Optics
Series A in 2020
Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations. Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens. They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel. And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button. In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see.
Animab
Seed Round in 2020
Animab is a biotechnology company focused on enhancing livestock health through innovative monoclonal antibody technology. By leveraging advanced research in animal science, Animab develops products that aim to improve animal welfare, reduce operational costs, and promote sustainability in livestock farming. Their proprietary antibodies are designed to mimic secretory IgA, a natural antibody found in colostrum and milk, which provides critical protection for piglets during the vulnerable post-weaning phase. These antibodies target specific intestinal pathogens while preserving the healthy microbiome, ensuring that piglets remain healthy and resilient during this crucial developmental period. Through its solutions, Animab seeks to benefit animals, producers, and consumers alike.
Ziggu
Seed Round in 2020
Ziggu is a proptech company that provides digital solutions for real estate professionals, focusing on enhancing communication and management throughout the construction process. Its primary offering, Ziggu Engage, allows residential property developers to securely manage and track customer information while enabling homebuyers to access updates on construction details, browse documents, schedule appointments, and monitor invoices through a personal online platform. Additionally, Ziggu Construction View serves as a standalone tool for various construction professionals, including general contractors and architects, facilitating project organization, document sharing, and transaction history tracking. This comprehensive approach aims to simplify the complexities of construction management and improve engagement between developers and homebuyers.
Indigo Diabetes
Series B in 2020
Indigo Diabetes, established in 2016 and headquartered in Ghent, Belgium, specializes in developing innovative, non-invasive glucose monitoring solutions. The company's flagship product is an invisible, photonics-based sensor that is inserted under the skin, continuously measuring blood sugar levels, thereby eliminating the need for traditional finger pricks. Indigo Diabetes aims to enhance the lives of people with diabetes by providing accurate glucose monitoring with an improved user experience.
Qollabi
Seed Round in 2020
Qollabi is a developer of Business Relationship Management (BRM) software aimed at facilitating the management of indirect sales channels, such as agents, distributors, and resellers. The software provides tools for creating centralized partner plans that promote collaboration and communication within teams. It allows users to update action plans and connect with customer relationship management (CRM) systems and other data sources. By leveraging the OKR (Objective & Key Results) methodology, Qollabi enables organizations to establish shared spaces for planning and achieving mutual success with their partners. This approach enhances the effectiveness of partnerships and streamlines the management of business relationships.
CHILI Publish
Venture Round in 2020
CHILI Publish is a Belgium-based company that specializes in online editing software designed to transform original designs into Smart Templates. Founded in 2010 and headquartered in Erembodegem, the company aims to simplify and automate graphic production for businesses across various industries, including marketing, retail, cosmetics, and food and beverage. Its innovative software provides a comprehensive suite of templates and customizable features that facilitate the creation of on-brand visual communications for both print and packaging. By integrating with a wide range of third-party partners, CHILI Publish enables marketers, brands, and printers to utilize a self-service platform, enhancing efficiency in producing graphics for diverse purposes.
etherna immunotherapies
Series B in 2020
eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.
ViroVet
Series B in 2020
ViroVet is an innovative company focused on developing groundbreaking technologies to combat viral diseases in livestock, particularly through antiviral drugs targeting respiratory disease complexes and novel vaccines for swine. The livestock industry, valued at over 100 billion euros, faces significant financial losses due to viral diseases, which threaten global animal protein supplies. ViroVet aims to supply livestock producers, national governments, and international organizations with comprehensive solutions that can be used independently or alongside existing vaccines and biosecurity measures. With the growing world population and increased demand for protein, the risk of viral disease spread in densely populated livestock environments is rising. ViroVet has garnered support from key opinion leaders in livestock medicine, who recognize the potential of its products to reduce antibiotic use and transform the industry. Through its innovative approach, ViroVet addresses urgent challenges posed by endemic and epizootic viral diseases, ultimately aiming to enhance the resilience of the livestock sector.
TechWolf
Seed Round in 2020
TechWolf is a company that specializes in an AI-based talent intelligence platform aimed at helping enterprises transition to a skills-based talent model. The platform automatically tracks employees’ skills by analyzing HR information and their digital interactions in the workplace. By utilizing artificial intelligence, TechWolf's software provides organizations with a comprehensive view of their workforce's skills and identifies skill gaps, offering actionable insights regarding current and future skill requirements. This enables companies to make informed decisions that enhance both individual employee development and overall organizational effectiveness.
InvestSuite
Seed Round in 2020
InvestSuite is a B2B fintech company that provides financial institutions with white-label solutions to enhance their wealth management offerings. The company specializes in developing investment applications that include modular robo-advisory services and self-execution trading platforms. These tools allow institutions to launch their own financial products efficiently and cost-effectively, minimizing the need for significant capital investments. By leveraging advanced technologies like AI and machine learning, InvestSuite helps financial businesses tailor their services to meet the diverse needs of their clients, optimizing investment returns based on individual risk tolerance and financial goals. With a team of experienced experts, InvestSuite is positioned to support the evolving landscape of financial services amid changing customer expectations and technological advancements.
THEO Technologies
Series A in 2020
THEO Technologies specializes in universal video playback technologies designed to enhance the video experience across various platforms and devices. The company provides a universal media player that streamlines the deployment of premium playback experiences for media companies, particularly in the over-the-top (OTT) application market. By enabling online media enterprises to deliver a consistent video playback experience, THEO Technologies helps these organizations save time and resources while reaching audiences globally.
QustomDot
Seed Round in 2020
QustomDot is a company based in Ghent, Belgium, specializing in the development and manufacturing of on-chip grade and cadmium-free quantum dots. These tiny semiconductor nanoparticles are designed to transform ultraviolet or blue light into pure colors, enhancing the image quality of various display technologies. QustomDot's products are applicable in LED/LCD televisions, smartphones, smartwatches, virtual and augmented reality goggles, and LED lighting solutions. The company not only produces quantum dots but also assists customers in integrating these advanced materials into their products, helping to improve color gamut and energy efficiency. Founded in 2020, QustomDot is focused on innovation in the field of advanced materials.
IVEX
Seed Round in 2020
IVEX is a start-up originating from the University of Leuven, specializing in the development of tools and software designed for the testing and validation of advanced driver assistance systems (ADAS) and autonomous vehicles. The company comprises a diverse team and has established partnerships with global firms, notably Siemens, to enhance its growth in the high-tech sector. IVEX offers a cloud-based suite of testing and validation tools alongside an onboard real-time safety checker, which can function independently or in conjunction with other systems. Its solutions streamline the analysis of extensive driving data, enabling engineers to efficiently identify and categorize driving scenarios, create digital representations for simulation, and assess safety performance while minimizing computational resource usage. By focusing on safety and efficiency, IVEX aims to support the industry's need for reliable and effective validation of automated driving technologies.
Dockflow
Seed Round in 2020
Dockflow operates a blockchain-based platform designed to enhance the efficiency and experience of logistics teams. By providing tools for maritime container shipment visibility, tracking, and sensitive cargo monitoring, Dockflow streamlines operations and reduces the burden of manual checks and data management. The platform also facilitates collaboration among logistics professionals, allowing them to focus on delivering better service to customers and engaging in more meaningful tasks. Overall, Dockflow aims to transform logistics operations by automating routine processes and improving communication within the industry.
MICLEDI Microdisplays
Seed Round in 2020
MICLEDI Microdisplays BV specializes in designing and manufacturing micro light-emitting diode (microLED) display chips tailored for augmented reality (AR) glasses. Based in Leuven, Belgium, the company operates as a fabless developer, focusing on advanced technology that integrates III/V materials processing, 3D integration, and 300mm silicon-based processing. MICLEDI's proprietary application-specific integrated circuit (ASIC) enables the production of compact, monolithic AR displays that deliver high image quality and enhanced power efficiency. By providing microLED display modules on wafers, MICLEDI serves the semiconductor industry, contributing to the advancement of AR technology.
Augustine Therapeutics
Seed Round in 2019
Augustine Therapeutics N.V., founded in 2019 and based in Gent, Belgium, focuses on developing innovative medicines for patients suffering from Charcot-Marie-Tooth disease and other neuromuscular disorders. The company is engaged in two drug discovery programs aimed at identifying new generations of selective HDAC6 inhibitors, which are designed to address axonopathies, including Charcot-Marie-Tooth disease. These novel compounds are intended to protect against nerve degeneration and facilitate the repair of peripheral myelin and axons. By advancing these therapeutic drugs, Augustine Therapeutics aims to enhance the quality of life for patients affected by these debilitating conditions.
Biotalys
Series C in 2019
Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.
Unifly
Series B in 2019
Unifly is a developer of unmanned traffic management software focused on the secure integration of drones into global airspace. Founded in 2015 by aerospace experts, the company emerged from a vision shared by air traffic controllers who recognized the need for effective management of the increasing number of drones. Unifly's award-winning platform connects authorities and drone operators, allowing for real-time monitoring and management of drone traffic, while providing pilots with essential information regarding the legal status of their flights. The platform is already utilized by national authorities in Germany, Denmark, Austria, and Belgium, and Unifly is also active in the United States and several projects worldwide, including Africa and Asia. By fostering collaboration with various stakeholders, Unifly aims to enhance airspace safety and facilitate the seamless integration of drones into everyday life, addressing critical concerns regarding safety and oversight in both recreational and commercial drone activities.
Confo Therapeutics
Series A in 2019
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company focuses on developing internal drug discovery programs centered on G-protein coupled receptors (GPCRs), which are critical targets for therapeutic intervention. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes active-state conformations of GPCRs, enabling researchers to access previously unreachable structural features. This innovation facilitates the discovery of novel agonists, addressing unmet medical needs and potentially leading to improved treatments in the medical field. The company aims to build a robust portfolio of drug discovery programs, leveraging its unique approach to enhance therapeutic options.
SupplyStack
Series A in 2019
SupplyStack, based in Antwerp, Belgium, provides a real-time visibility solution for monitoring transport orders, enabling effective collaboration and automating various logistical processes. The company offers a comprehensive platform that integrates a visibility solution with a transport management system, allowing users to track and manage logistics efficiently. SupplyStack serves a diverse range of industries, including automotive, industrial manufacturing, FMCG, chemicals, wholesale and distribution, pharmaceuticals, and food and beverage. Its software facilitates real-time monitoring and planning of transportation flows, helping logistics service providers and shippers enhance operational efficiency and reduce costs while improving overall service quality.
reMYND
Venture Round in 2018
reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for Alzheimer’s, Parkinson’s, diabetes, and other protein-misfolding disorders. The company is advancing several investigational compounds, including ReS19-T for Alzheimer’s and ReS39 for diabetes, as well as ReS3-T, which targets neuronal hyperactivity associated with Alzheimer’s and epilepsy. Additionally, reMYND operates a phenotypic screening platform aimed at discovering small molecule treatments that mitigate the toxicity of misfolded proteins such as Tau and Synuclein. The company also functions as a contract research organization (CRO), providing services that assess the in-vivo characteristics and effects of experimental therapies using proprietary mouse models. This CRO capability has enabled reMYND to support various pharmaceutical clients, including major companies in the United States, Europe, and Japan, by delivering critical proof-of-concept data for drugs in clinical development. Established in 2002, reMYND is committed to addressing the challenges posed by protein misfolding diseases through innovative research and development.
InvestSuite
Seed Round in 2018
InvestSuite is a B2B fintech company that provides financial institutions with white-label solutions to enhance their wealth management offerings. The company specializes in developing investment applications that include modular robo-advisory services and self-execution trading platforms. These tools allow institutions to launch their own financial products efficiently and cost-effectively, minimizing the need for significant capital investments. By leveraging advanced technologies like AI and machine learning, InvestSuite helps financial businesses tailor their services to meet the diverse needs of their clients, optimizing investment returns based on individual risk tolerance and financial goals. With a team of experienced experts, InvestSuite is positioned to support the evolving landscape of financial services amid changing customer expectations and technological advancements.
Sequana Medical
Series D in 2018
Sequana Medical AG is a Swiss medical device company that specializes in developing implantable pump systems to manage fluid balance in the body. Its flagship product, the alfapump, is designed to continuously remove ascites, a condition characterized by fluid accumulation in the abdominal cavity, commonly seen in patients with advanced liver disease, certain cancers, or congestive heart failure. The alfapump is notable for being the first automated system that facilitates the natural expulsion of excess fluid through urination. In addition to treating ascites, the company's pump technology has potential applications in managing pleural effusions and fluid overload in patients with end-stage renal disease and heart failure. Founded in 2002 and headquartered in Zurich, Switzerland, Sequana Medical has expanded its reach to various markets, with a significant portion of its revenue generated in Germany.
StoryChief
Seed Round in 2018
StoryChief.io is a content marketing software designed for startups, SEO marketers, and editorial teams seeking to streamline their content creation and distribution processes. The platform enables users to publish stories across multiple channels, including WordPress, Medium, newsletters, and various social media platforms, all from a single interface. Its universal editor allows for the easy creation of visually appealing articles tailored for different publishing formats. Additionally, StoryChief offers features such as SEO suggestions, performance tracking, and lead capture integration with CRM systems, helping users measure their impact and return on investment effectively. By centralizing content management, StoryChief enhances the reach and efficiency of content marketing efforts.
Loop Earplugs
Debt Financing in 2018
Loop Earplugs develops innovative earplugs that prioritize both ear protection and sound clarity. Designed as fashionable accessories, these earplugs filter noise rather than completely blocking it, allowing users to experience clear sound while reducing harmful decibel levels. This unique approach makes them suitable for a variety of environments, including concerts, events, and sports, where loud noises can be prevalent. By empowering individuals to choose how they hear the world, Loop Earplugs addresses the need for effective hearing protection without sacrificing the quality of sound.
Teamleader
Series C in 2018
Teamleader, based in Belgium, is a software company that provides a comprehensive platform for project management and invoicing, aimed at helping entrepreneurs streamline their business operations. With over 7,000 paying customers, the company has experienced significant growth and is poised for further expansion. Teamleader's user-friendly interface, competitive pricing, and extensive integrations make it an appealing choice for businesses looking to manage their sales, project management, calendar, time tracking, invoicing, and ticketing in one place. By simplifying these essential functions, Teamleader enables clients to save time and focus on increasing their revenue.
Morrow Optics
Series A in 2018
Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations. Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens. They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel. And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button. In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see.
Pick-it
Series A in 2018
Pick-it specializes in developing 3D vision systems that enable precise guidance for robotic applications. The company's technology includes advanced 3D cameras and software capable of detecting the position, orientation, and dimensions of various products, facilitating tasks such as bin picking, depalletization, kitting, and assembly. By providing solutions for overlapping products of different sizes, Pick-it enhances automation capabilities in organizations that utilize industrial robots, streamlining processes in machine loading and conveyor handling.
Unifiedpost Group
Venture Round in 2018
Unifiedpost Group is a Belgian company that specializes in providing a cloud-based platform for administrative and financial services. Founded in 2001 and headquartered in La Hulpe, it facilitates digital connections between businesses, suppliers, and customers across various sectors, including corporate, government, agriculture, and construction. The company offers a range of solutions, including document processing, identity verification, payment automation, and procurement services, aimed at simplifying and enhancing business operations. Its invoicing solutions help organizations transition to electronic invoicing while ensuring compliance with local tax regulations. Additionally, Unifiedpost Group provides flexible invoice financing options to help small and medium-sized enterprises access working capital when needed. Overall, the company's platform is designed to streamline financial transactions and improve operational efficiency for its clients.
PieSync
Venture Round in 2018
PieSync is a developer of a synchronization application that facilitates real-time contact syncing between various cloud applications. By enabling bidirectional synchronization, PieSync allows users to manage their contacts, emails, calendars, tasks, and documents seamlessly. The application operates in the background, ensuring that contacts are consistently updated across different platforms, which significantly enhances productivity for business users by integrating their favorite web applications.
Ontoforce
Series A in 2018
ONTOFORCE is a company that specializes in enhancing research and drug development within the life sciences sector by enabling organizations to uncover valuable insights from disparate data sources. Its primary product, DISQOVER, is a knowledge discovery platform built on semantic technology and ontology-based structures. This platform integrates an organization’s internal data with licensed and public data, facilitating efficient exploration and analysis. DISQOVER is user-friendly and customizable, catering to a diverse audience that includes scientific researchers, bioinformaticians, and data scientists. With over 10,000 global users, ONTOFORCE's solutions are adopted by many prominent pharmaceutical and biotechnology firms. The company is headquartered in Ghent, Belgium, and maintains a secondary office in Cambridge, Massachusetts.
LindaCare
Series B in 2018
LindaCare LTD. is a Belgium-based company that specializes in developing a tele-monitoring dashboard for patients with chronic diseases, particularly those with cardiac implantable devices. The software integrates data from various device vendors and electronic patient records, enhancing workflow efficiency and reducing the risk of medical errors through customized alerts. By offering a vendor-independent platform, LindaCare aims to simplify the tele-monitoring process for healthcare professionals and hospitals, ultimately reducing the cost of care delivery while improving patient safety and the overall quality of care. This unified approach facilitates better tracking and monitoring of patient activities, benefiting both healthcare providers and family members involved in patient care management.
PharmaFluidics
Venture Round in 2018
PharmaFluidics is a spin-off from the Vrije Universiteit Brussel that specializes in developing innovative micro-chip-based chromatography columns for applications in biomarker detection, diagnostics, and drug research and development. The company focuses on creating integrated milli- to nano-engineered solutions tailored for mixing, separation, and reaction processes, leveraging its expertise in chemical engineering and micro-fabrication technology. By providing high-quality, custom solutions, PharmaFluidics aims to enhance the sensitivity and accuracy of detecting active compounds in complex biological samples, including biopsies and proteome digests. This approach supports researchers in their efforts to achieve more effective analytical separations, ultimately benefiting the chemical and life sciences industries.
Aelin Therapeutics
Series A in 2017
Aelin Therapeutics is a Belgian biotherapeutics company established in 2017 and headquartered in Heverlee. It specializes in developing innovative antibiotics and therapeutics through its proprietary Pept-in technology, which utilizes protein aggregation to achieve functional knockdown of target proteins. This platform is designed to address challenging medical conditions, including infections caused by Methicillin-resistant Staphylococcus aureus (MRSA) and other undruggable targets in humans. The company was founded by VIB in collaboration with partner universities, including KU Leuven, VUB, and UGent, and is backed by extensive preclinical proof-of-concept data. Aelin Therapeutics' approach allows for the rational design of novel biotherapeutics, distinguishing itself from traditional therapeutic modalities by targeting intracellular spaces typically inaccessible to small molecules or antibodies. The technology's versatility extends beyond human applications, demonstrating efficacy against bacteria, cancer cells, fungi, viruses, and even plant cells.
LynxCare
Debt Financing in 2017
LynxCare, established in 2015 and headquartered in San Francisco, specializes in an AI-driven data platform. It collects and analyzes structured and unstructured data from diverse sources, offering hospitals and clinics actionable insights to enhance clinical efficiency and improve patient care quality.
FEops
Series B in 2017
FEops is a pioneer in physics-based simulations specifically tailored for minimally invasive cardiovascular devices and procedures. The company develops advanced cardiac imaging technology that enhances personalized treatment for patients with structural heart disease. By utilizing artificial intelligence to conduct anatomical analyses, FEops provides data-driven insights that improve transcatheter valve procedures through personalized computer simulations. This approach offers medical device companies and healthcare professionals unique insights that streamline research and development processes, enhance procedural efficiency, and ultimately improve clinical outcomes and patient safety. Additionally, FEops supports medical specialists and physicians with patient-specific information, facilitating more effective treatments.
Laminaria
Venture Round in 2017
Laminaria, founded in 2011 and based in Ostend, Belgium, specializes in manufacturing wave energy converter equipment. The company is at the forefront of developing technology designed to harness renewable wave energy, using a system that converts tilting and translating motions into power through mooring ropes connected to generators. Laminaria leads the LAMWEC project, a consortium of ocean energy experts that includes organizations such as EMEC, Innosea, Ghent University, and TTI Testing. Through its innovative technology, Laminaria aims to significantly impact the renewable energy landscape by advancing the effectiveness and efficiency of wave energy conversion.
Aphea.Bio
Series A in 2017
Aphea.Bio focuses on developing innovative agricultural products aimed at enhancing crop health and yields. The company specializes in creating next-generation biopesticides derived from natural microorganisms, which serve as sustainable alternatives to traditional chemical pesticides facing regulatory challenges. Additionally, Aphea.Bio produces biostimulants that promote crop growth by enhancing nutrient uptake from the soil. Utilizing proprietary technologies, the company is dedicated to discovering new biocontrol and biostimulant products that help farmers sustainably manage fungal diseases, pests, and weeds, ultimately improving crop productivity and environmental health.
Luxexcel
Series C in 2017
Luxexcel is a pioneering company that specializes in 3D printing technology for lenses and optical products. It is the only organization globally capable of 3D printing prescription lenses, positioning itself at the forefront of innovation in the eyewear industry. The company has developed a comprehensive suite of components, including hardware, software, processes, and materials, which enables customers to produce high-quality, custom optical lenses. Luxexcel's unique printing technology ensures the creation of optically smooth structures and surfaces, allowing clients to benefit from cost-effective lens production while enhancing product customization. By collaborating with technology partners, Luxexcel is also facilitating the development of advanced smart eyewear, opening new possibilities for the industry.
Biotalys
Series B in 2017
Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.
Newtec
Secondary Market in 2017
Newtec is a Belgian company that specializes in designing, developing, and manufacturing equipment and technologies for satellite communications. Established in 1985, Newtec offers a range of products, including modems, satellite terminals, hubs, modulators, demodulators, redundancy switches, receivers, and multiservice broadcast terminals. These products are used across various sectors, including broadcast, government, defense, and enterprise VSAT services. With over 30 years of experience, Newtec focuses on creating efficient, scalable, and cost-effective solutions that address the evolving needs of its customers. The company's commitment to innovation and excellence enables it to contribute to a safer, more informed, and better-connected world. Newtec maintains regional offices and research and development centers in multiple locations, including the United States, Singapore, China, the UAE, Brazil, Germany, and France.
Waylay
Seed Round in 2017
Waylay is a B2B software company that specializes in bridging the gap between operational technology (OT) and information technology (IT). It offers a range of products designed to facilitate digital transformation and enhance operational efficiency. Waylay IO provides low-code automation with no setup required, while Waylay Enterprise simplifies digital transformation for organizations. Additionally, Waylay Digital Twin is a composite application available on the Salesforce AppExchange. The platform aims to integrate various software applications and devices, enabling businesses to make informed decisions based on real-time data from connected equipment. With applications in sectors such as energy, logistics, and online retail, Waylay helps enterprises and small to medium-sized enterprises (SMEs) leverage data and analytical insights to improve operational processes and customer service.
PharmaFluidics
Venture Round in 2017
PharmaFluidics is a spin-off from the Vrije Universiteit Brussel that specializes in developing innovative micro-chip-based chromatography columns for applications in biomarker detection, diagnostics, and drug research and development. The company focuses on creating integrated milli- to nano-engineered solutions tailored for mixing, separation, and reaction processes, leveraging its expertise in chemical engineering and micro-fabrication technology. By providing high-quality, custom solutions, PharmaFluidics aims to enhance the sensitivity and accuracy of detecting active compounds in complex biological samples, including biopsies and proteome digests. This approach supports researchers in their efforts to achieve more effective analytical separations, ultimately benefiting the chemical and life sciences industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.